Literature DB >> 14980814

The life span of ganglionic glia in murine sensory ganglia estimated by uptake of bromodeoxyuridine.

Karen Elson1, Ruy M Ribeiro, Alan S Perelson, Anthony Simmons, Peter Speck.   

Abstract

Studies of ganglionic glia turnover in the sensory nervous system have implications for understanding nervous system maintenance and repair. These glial cells of the sensory ganglia in the peripheral nervous system (PNS) comprise satellite cells (SCs) and, to a lesser extent, Schwann cells. SCs proliferate in response to trauma such as axotomy; however, the half-life of these glial cells under normal circumstances has not been estimated. To estimate the half-life of sensory ganglionic glial cells, we employed the DNA precursor analog 5-bromo-2'-deoxyuridine (BrdU) to measure the rate of turnover of these cells. BrdU was administered to inbred C57BL6 and outbred Swiss white mice via their drinking water. BrdU incorporation into ganglionic glia in the PNS was estimated by immunofluorescent staining of nervous tissue sections, and the fraction of ganglionic glial cells that acquired BrdU label was measured as a function of time. Mathematical modeling of the rate of uptake of BrdU into murine ganglionic glia enables calculation of the half-life of these cells. The kinetics of BrdU uptake is linear, consistent with ganglionic glia being a homogenous population. The value of the proliferation rate (p) plus death rate (d) derived from the slope of BrdU uptake as a function of time is approximately 2.4 x 10(-3) cells per day. Assuming that p = d (because ganglionic glial numbers are in equilibrium and they are assumed to neither emigrate from, or immigrate into, sensory ganglia), then the daily death rate is d = 1.2 x 10(-3) cells/day, which implies a half-life for ganglionic glia of about 600 days. Thus murine ganglionic glia in the untraumatized state appear to behave as a homogenous, slowly replicating population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14980814     DOI: 10.1016/j.expneurol.2003.10.017

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  5 in total

1.  Can satellite glial cells be therapeutic targets for pain control?

Authors:  Luc Jasmin; Jean-Philippe Vit; Aditi Bhargava; Peter T Ohara
Journal:  Neuron Glia Biol       Date:  2010-06-22

2.  Mathematical model on Alzheimer's disease.

Authors:  Wenrui Hao; Avner Friedman
Journal:  BMC Syst Biol       Date:  2016-11-18

3.  Ribosomal trafficking is reduced in Schwann cells following induction of myelination.

Authors:  James M Love; Sameer B Shah
Journal:  Front Cell Neurosci       Date:  2015-08-19       Impact factor: 5.505

4.  Intracerebroventricular administration of nerve growth factor induces gliogenesis in sensory ganglia, dorsal root, and within the dorsal root entry zone.

Authors:  Johannes C M Schlachetzki; Donald P Pizzo; Debbi A Morrissette; Jürgen Winkler
Journal:  Biomed Res Int       Date:  2014-03-16       Impact factor: 3.411

5.  Satellite glial cells surrounding primary afferent neurons are activated and proliferate during monoarthritis in rats: is there a role for ATF3?

Authors:  Diana Sofia Marques Nascimento; José Manuel Castro-Lopes; Fani Lourença Moreira Neto
Journal:  PLoS One       Date:  2014-09-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.